CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,080,782 | -20.6% | 25,809 | +6.5% | 0.00% | -20.0% |
Q2 2023 | $1,360,665 | +15.9% | 24,237 | -6.6% | 0.01% | 0.0% |
Q1 2023 | $1,173,997 | +10.2% | 25,956 | -1.0% | 0.01% | 0.0% |
Q4 2022 | $1,065,502 | -36.1% | 26,212 | +2.7% | 0.01% | -50.0% |
Q3 2022 | $1,667,000 | +15.4% | 25,511 | +7.3% | 0.01% | +11.1% |
Q2 2022 | $1,445,000 | +9.7% | 23,784 | +13.3% | 0.01% | 0.0% |
Q1 2022 | $1,317,000 | -30.4% | 20,984 | -16.0% | 0.01% | -30.8% |
Q4 2021 | $1,893,000 | -3.2% | 24,984 | +43.0% | 0.01% | -18.8% |
Q3 2021 | $1,955,000 | -43.1% | 17,466 | -17.8% | 0.02% | -50.0% |
Q2 2021 | $3,438,000 | +27.9% | 21,239 | -3.7% | 0.03% | +10.3% |
Q1 2021 | $2,687,000 | +1.7% | 22,050 | +27.8% | 0.03% | -17.1% |
Q4 2020 | $2,642,000 | +81.3% | 17,253 | -1.3% | 0.04% | +45.8% |
Q3 2020 | $1,457,000 | -3.4% | 17,478 | -9.1% | 0.02% | -4.0% |
Q2 2020 | $1,509,000 | +111.6% | 19,225 | +3.8% | 0.02% | +56.2% |
Q1 2020 | $713,000 | -18.4% | 18,514 | +25.6% | 0.02% | +14.3% |
Q4 2019 | $874,000 | +2031.7% | 14,739 | +1373.9% | 0.01% | +1300.0% |
Q3 2019 | $41,000 | -12.8% | 1,000 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $47,000 | +30.6% | 1,000 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $36,000 | +620.0% | 1,000 | +1134.6% | 0.00% | – |
Q2 2018 | $5,000 | – | 81 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |